Position in NXTC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$293,678
New position
Shares Held
27,498
first reported quarter
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. NXTC ranks #185 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | QNCX |
Quince Therapeutics, Inc.
|
5,200,000 | $105,040,000 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 |
All Filings in NXTC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $293,678 | 27,498 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||